IRVINE, Calif., Jan. 30, 2017 /PRNewswire/ -- Syneron Medical
Ltd. (NASDAQ:ELOS), a leading global aesthetic device company,
today announced that it will release fourth quarter and full year
2016 financial results before the market opens on Wednesday,
February 15, 2017. The earnings release will be available on
Syneron's website at www.investors.syneron.com.
Syneron management will host a conference call and a live
webcast at 8:30 a.m. (ET) on the same day. A question
& answer session will follow management's discussion of events
in the fourth quarter and full year 2016.
Investors and analysts may participate in the conference call
using the following dial-in numbers:
US (toll
free):
|
(877)
280-1254
|
International:
|
(646)
254-3366
|
The conference passcode for both is 2212875.
Investors and other interested parties can also access a live
webcast of the conference call through the Investor Relations page
on Syneron's website at www.investors.syneron.com. Please log-in at
least 10 minutes prior to the conference call in order to download
the applicable audio software. Following the conclusion of the
call, a replay of the webcast will be available within 24 hours on
the Company's website.
About Syneron Candela:
Syneron Candela is a
leading global aesthetic device company with a comprehensive
product portfolio and a global distribution footprint. The
Company's technology enables physicians to provide advanced
solutions for a broad range of medical-aesthetic applications
including body contouring, hair removal, wrinkle reduction, tattoo
removal, women's intimate wellness treatments, improving the skin's
appearance through the treatment of superficial benign vascular and
pigmented lesions, and the treatment of acne, leg veins and
cellulite. The Company has a wide portfolio of trusted, leading
products including UltraShape, VelaShape, GentleLase, VBeam
Perfecta, PicoWay, CO2RE, CO2RE Intima, Profound and elōs Plus.
Founded in 2000, the company markets, services and supports its
products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
For additional information, please visit
http://www.syneron-candela.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/syneron-medical-to-report-fourth-quarter-and-full-year-2016-financial-results-on-february-15-2017-300398486.html
SOURCE Syneron Medical Ltd.